首页|期刊导航|中草药（英文版）|Cardiometabolic reprogramming in pulmonary arterial hypertension:Implications for right ventricular dysfunction and therapeutic strategies

Cardiometabolic reprogramming in pulmonary arterial hypertension:Implications for right ventricular dysfunction and therapeutic strategies

Guanghui Qian Peng Zhang Gaurav Choudhary Hongwei Yao

中草药（英文版）2026，Vol.18Issue(3)：515-527,13.

中草药（英文版）2026，Vol.18Issue(3)：515-527,13.DOI:10.1016/j.chmed.2026.04.004

Cardiometabolic reprogramming in pulmonary arterial hypertension:Implications for right ventricular dysfunction and therapeutic strategies

Guanghui Qian ¹Peng Zhang ¹Gaurav Choudhary ¹Hongwei Yao²

作者信息

1. Providence VA Medical Center,Providence 02908,USA||Department of Medicine,Warren Alpert Medical School of Brown University,Providence 02903,USA
2. Providence VA Medical Center,Providence 02908,USA||Department of Medicine,Warren Alpert Medical School of Brown University,Providence 02903,USA||Department of Molecular Biology,Cell Biology & Biochemistry,Division of Biology and Medicine,Brown University,Providence 02906,USA
折叠

摘要

关键词

metabolic modulators/natural products/pulmonary arterial hypertension/RV fibrosis/RV maladaptation

Key words

metabolic modulators/natural products/pulmonary arterial hypertension/RV fibrosis/RV maladaptation

引用本文复制引用

Guanghui Qian,Peng Zhang,Gaurav Choudhary,Hongwei Yao..Cardiometabolic reprogramming in pulmonary arterial hypertension:Implications for right ventricular dysfunction and therapeutic strategies[J].中草药（英文版）,2026,18(3):515-527,13.

基金项目

This work was supported in part by the NIH grant R01HL166327,an Institutional Development Award(IDeA)from the NIGMS of NIH under grant P30GM149398.The views expressed in this article are those of the authors and do not reflect the posi-tion or policy of the Department of Veterans Affairs or the US Fed-eral Government. （IDeA）

中草药（英文版）

ISSN：1674-6384

访问量0

下载量0

段落导航